Molecular and functional imaging of cancer: advances in MRI and MRS.

Publisher Summary This chapter presents an overview of the endogenous and exogenous magnetic resonance (MR) contrast mechanisms utilized in characterizing tumor vasculature. Every contrast mechanism for probing the tumor vasculature, including the use of exogenous MR contrast agents, is in some way a result of the changes in the MR signal intensity brought about by changes in tissue relaxation times. Noninvasive multinuclear magnetic resonance imaging (MRI) and MR spectroscopic imaging (MRSI) provide a wealth of spatial and temporal information on tumor vasculature, metabolism, and physiology. The most commonly used MR contrast agents (CA) are paramagnetic gadolinium chelates. These agents are tightly bound complexes of the rare earth element gadolinium and various chelating agents. A simple linear compartment model, describing uptake of the contrast agent from plasma, postulates a negligible reflux of the contrast agent from the interstitium back to the blood compartment. Blood concentrations of the CA can be approximated to be constant for the duration of the MR experiment, and under these conditions, contrast uptake is a linear function of time. The MR detection of cellular targets is also elaborated.

[1]  P. Okunieff,et al.  Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy. , 1988, Journal of the National Cancer Institute.

[2]  P. Tofts Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[3]  R. Lauffer,et al.  Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design , 1987 .

[4]  P D Ellis,et al.  An integrated confocal and magnetic resonance microscope for cellular research. , 2000, Journal of magnetic resonance.

[5]  Michal Neeman,et al.  In Vivo Prediction of Vascular Susceptibility to Vascular Endothelial Growth Factor Withdrawal Magnetic Resonance Imaging of C6 Rat Glioma in Nude Mice , 1999 .

[6]  B R Rosen,et al.  NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.

[7]  S. Sapareto,et al.  In vivo metabolic effects of hyperglycemia in murine radiation-induced fibrosarcoma: a 31P NMR investigation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Jose M. Silva,et al.  Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy , 2002, Oncogene.

[9]  J. M. Arbeit,et al.  Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy. , 1992, Cancer research.

[10]  R G Shulman,et al.  NMR studies of enzymatic rates in vitro and in vivo by magnetization transfer , 1984, Quarterly Reviews of Biophysics.

[11]  S. H. Koenig,et al.  Determinants of Proton Relaxation Rates in Tissue , 1984, Magnetic resonance in medicine.

[12]  S. Ogawa,et al.  Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.

[13]  D Artemov,et al.  Combined vascular and extracellular pH imaging of solid tumors , 2002, NMR in biomedicine.

[14]  J R Griffiths,et al.  The energy metabolism of RIF-1 tumours following hydralazine. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  J A Frank,et al.  Synthesis and relaxometry of high‐generation (G = 5, 7, 9, and 10) PAMAM dendrimer‐DOTA‐gadolinium chelates , 1999, Journal of magnetic resonance imaging : JMRI.

[16]  J. Bulte,et al.  Short‐ vs. long‐circulating magnetoliposomes as bone marrow‐seeking MR contrast agents , 1999, Journal of magnetic resonance imaging : JMRI.

[17]  U Schmiedl,et al.  Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. , 1987, Radiology.

[18]  P. Lantos,et al.  The vasculature of experimental brain tumours Part 1. A sequential light and electron microscope study of angiogenesis , 1981, Journal of the Neurological Sciences.

[19]  Andrew G. Webb,et al.  Radiofrequency microcoils in magnetic resonance , 1997 .

[20]  M. Leach,et al.  Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells , 2001, British Journal of Cancer.

[21]  Jeff W. M. Bulte,et al.  Synthesis and Characterization of Soluble Iron Oxide−Dendrimer Composites , 2001 .

[22]  D L Buckley,et al.  MR microscopy of multicomponent diffusion in single neurons , 2001, Magnetic resonance in medicine.

[23]  W. Ebert,et al.  The Demonstration of Human Tumors on Nude Mice Using Gadolinium‐Labelled Monoclonal Antibodies for Magnetic Resonance Imaging , 1993, Investigative radiology.

[24]  J. Denekamp Limited role of vasculature-mediated injury in tumor response to radiotherapy. , 1993, Journal of the National Cancer Institute.

[25]  R. Rosell,et al.  Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. , 2002, Biochemical and biophysical research communications.

[26]  K D Pettigrew,et al.  Local Cerebral Blood Flow in the Conscious Rat As Measured with 14C-Antipyrine, 14C-Iodoantipyrine and 3H-Nicotine , 1979, Stroke.

[27]  A P Pathak,et al.  Utility of simultaneously acquired gradient‐echo and spin‐echo cerebral blood volume and morphology maps in brain tumor patients , 2000, Magnetic resonance in medicine.

[28]  B. Quesson,et al.  [1‐13C]Glucose Metabolism in the Tumoral and Nontumoral Cerebral Tissue of a Glioma‐Bearing Rat , 1999, Journal of neurochemistry.

[29]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[30]  A P Pathak,et al.  MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.

[31]  Z. Bhujwalla,et al.  Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.

[32]  L. Axel Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. , 1980, Radiology.

[33]  Z. Bhujwalla,et al.  Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. , 2002, Neoplasia.

[34]  Scott D Rand,et al.  The effect of brain tumor angiogenesis on the in vivo relationship between the gradient‐echo relaxation rate change (ΔR2*) and contrast agent (MION) dose , 2003, Journal of magnetic resonance imaging : JMRI.

[35]  S M Wright,et al.  Arrays of mutually coupled receiver coils: Theory and application , 1991, Magnetic resonance in medicine.

[36]  P Okunieff,et al.  Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. , 1989, Radiation research.

[37]  G Brix,et al.  Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. , 1997, Cancer research.

[38]  D. Noh,et al.  Overexpression of phospholipase D1 in human breast cancer tissues. , 2000, Cancer letters.

[39]  D. Shahbazi-Gahrouei,et al.  In vivo studies of Gd‐DTPA‐monoclonal antibody and gd‐porphyrins: Potential magnetic resonance imaging contrast agents for melanoma , 2001, Journal of magnetic resonance imaging : JMRI.

[40]  J Kurhanewicz,et al.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. , 2000, Neoplasia.

[41]  K. Schmainda,et al.  Water exchange and inflow affect the accuracy of T1‐GRE blood volume measurements: Implications for the evaluation of tumor angiogenesis , 2002, Magnetic resonance in medicine.

[42]  D Artemov,et al.  Two‐compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy , 1998, NMR in biomedicine.

[43]  V. L. Doyle,et al.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.

[44]  J R Griffiths,et al.  Proton NMR Observation of the Antineoplastic Agent Iproplatin In Vivo by Selective Multiple Quantum Coherence Transfer (Sel‐MQC) , 1995, Magnetic resonance in medicine.

[45]  D. Shungu,et al.  Band‐selective spin echoes for in vivo localized 1H NMR spectroscopy , 1994, Magnetic resonance in medicine.

[46]  H. Degani,et al.  The application of 13C NMR to the characterization of phospholipid metabolism in cells , 1992, Magnetic resonance in medicine.

[47]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[48]  B R Rosen,et al.  Improving MR quantification of regional blood volume with intravascular T1 contrast agents: Accuracy, precision, and water exchange , 1996, Magnetic resonance in medicine.

[49]  A. Webb,et al.  RF microcoil design for practical NMR of mass-limited samples. , 1998, Journal of magnetic resonance.

[50]  R. Weissleder,et al.  Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. , 2002 .

[51]  Stefan Miltenyi,et al.  Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles , 1992, Magnetic resonance in medicine.

[52]  Peter Caravan,et al.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. , 2002, Journal of the American Chemical Society.

[53]  B. Fenton,et al.  31P nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia. , 1988, Cancer research.

[54]  J. Griffiths,et al.  The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolism , 1992, NMR in biomedicine.

[55]  C. Sotak,et al.  A volume‐localized, two‐dimensional NMR method for the determination of lactate using zero‐quantum coherence created in a stimulated echo pulse sequence , 1988, Magnetic resonance in medicine.

[56]  A. Sherry,et al.  A novel europium(III)-based MRI contrast agent. , 2001, Journal of the American Chemical Society.

[57]  R J Maxwell,et al.  Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy. , 2001, Cancer research.

[58]  T. Ng,et al.  Application ofin vivo NMR spectroscopy to cancer , 1984, Magnetic resonance in medicine.

[59]  R. Gillies,et al.  Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber. , 2000, Neoplasia.

[60]  J W Belliveau,et al.  Ultrafast imaging of brain tumors , 1993, Topics in magnetic resonance imaging : TMRI.

[61]  Stephen J. Blackband,et al.  Nuclear magnetic resonance imaging of a single cell , 1986, Nature.

[62]  I. Gribbestad,et al.  1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non‐involved breast tissue , 1994, NMR in biomedicine.

[63]  P Mansfield,et al.  A microscope slide probe for high resolution imaging at 11.7 tesla , 1994, Magnetic resonance in medicine.

[64]  Donald S. Williams,et al.  Multi‐Slice MRI of Rat Brain Perfusion During Amphetamine Stimulation Using Arterial Spin Labeling , 1995, Magnetic resonance in medicine.

[65]  P. V. van Zijl,et al.  Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors. , 1995, Journal of magnetic resonance. Series B.

[66]  H. Degani,et al.  Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. , 1996, Anticancer research.

[67]  M. Garwood,et al.  Imaging blood flow in brain tumors using arterial spin labeling , 2000, Magnetic resonance in medicine.

[68]  J. Glickson,et al.  In Vivo 13C NMR spectroscopy of glucose metabolism of RIF‐1 tumors , 1991, Magnetic resonance in medicine.

[69]  Ellen Ackerstaff,et al.  Real‐time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti‐inflammatory agent indomethacin , 2002, Magnetic resonance in medicine.

[70]  Ying Lu,et al.  Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients , 2002, Journal of magnetic resonance imaging : JMRI.

[71]  I. Solomon Relaxation Processes in a System of Two Spins , 1955 .

[72]  A. Matsumura,et al.  MRI contrast enhancement by Gd-DTPA-monoclonal antibody in 9L glioma rats. , 1994, Acta neurochirurgica. Supplementum.

[73]  E. Rofstad,et al.  Radiation sensitivity of human ovarian carcinoma cell lines in vitro: effects of growth factors and hormones, basement membrane, and intercellular contact. , 1988, International journal of radiation oncology, biology, physics.

[74]  R E Hurd,et al.  Proton editing and imaging of lactate , 1991, NMR in biomedicine.

[75]  P. V. van Zijl,et al.  In Vivo proton spectroscopy and spectroscopic imaging of {1‐13C}‐g1ucose and its metabolic products , 1993 .

[76]  F. Podo Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[77]  A. Webb,et al.  Design of solenoidal microcoils for high-resolution 13C NMR spectroscopy. , 1998, Analytical chemistry.

[78]  M. Stampfer,et al.  Phospholipases A2 in ras-transformed and immortalized human mammary epithelial cells. , 1994, Cancer letters.

[79]  R. Brooks,et al.  Relaxometry and magnetometry of the MR contrast agent MION‐46L , 1999, Magnetic resonance in medicine.

[80]  B. Sitter,et al.  Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. , 1999, Anticancer research.

[81]  Richard L. Magin,et al.  Integrating microfabricated fluidic systems and NMR spectroscopy , 2000, IEEE Transactions on Biomedical Engineering.

[82]  E C Wiener,et al.  Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress. , 2000, Investigative radiology.

[83]  P. Roemer,et al.  The NMR phased array , 1990, Magnetic resonance in medicine.

[84]  R G Blasberg,et al.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[85]  R. Gillies,et al.  In Vitro and in Vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells , 1994, Magnetic resonance in medicine.

[86]  B. Rosen,et al.  Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.

[87]  R. B. Moon,et al.  Determination of intracellular pH by 31P magnetic resonance. , 1973, The Journal of biological chemistry.

[88]  Z. Bhujwalla,et al.  Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging , 1996, Magnetic resonance in medicine.

[89]  Eduard E de Lange,et al.  MRI of the lungs using hyperpolarized noble gases , 2002, Magnetic resonance in medicine.

[90]  B. Silvestrini,et al.  Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. , 1981, Journal of the National Cancer Institute.

[91]  P. V. van Zijl,et al.  Measurement of water–amide proton exchange rates in the denatured state of staphylococcal nuclease by a magnetization transfer technique , 1997, Proteins.

[92]  B. Rosen,et al.  Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects , 1988, Magnetic resonance in medicine.

[93]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[94]  P C Lauterbur,et al.  Design and analysis of microcoils for NMR microscopy. , 1995, Journal of magnetic resonance. Series B.

[95]  P. Joseph,et al.  Nuclear magnetic resonance and gamma camera tumor imaging using gadolinium-labeled monoclonal antibodies. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[96]  J. Gore,et al.  Intravascular susceptibility contrast mechanisms in tissues , 1994, Magnetic resonance in medicine.

[97]  Akira Hiraga,et al.  Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core , 2001, Magnetic resonance in medicine.

[98]  Y. Mardor,et al.  Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study. , 2001, Cancer research.

[99]  P. Okunieff,et al.  Evaluation of tumor energy metabolism and microvascular blood flow after glucose or mannitol administration using 31P nuclear magnetic resonance spectroscopy and laser Doppler flowmetry. , 1989, International journal of radiation oncology, biology, physics.

[100]  D Artemov,et al.  Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging. , 1998, Cancer research.

[101]  J. Nelson,et al.  Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. , 2001, Cancer research.

[102]  K. Brindle,et al.  The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets , 1993, Magnetic resonance in medicine.

[103]  Meiyappan Solaiyappan,et al.  Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[104]  W. A. Murphy,et al.  Magnetic resonance imaging using gadolinium labeled monoclonal antibody. , 1985, Investigative radiology.

[105]  J R Griffiths,et al.  An assessment of 31P MRS as a method of measuring pH in rat tumours , 1992, NMR in biomedicine.

[106]  Donald S. Williams,et al.  Detection of single mammalian cells by high-resolution magnetic resonance imaging. , 1999, Biophysical journal.

[107]  J. Kurhanewicz,et al.  Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.

[108]  Richard L. Magin,et al.  NMR spiral surface microcoils: Design, fabrication, and imaging , 2003 .

[109]  T Kubota,et al.  Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. , 1993, Radiology.

[110]  Jinyuan Zhou,et al.  Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI , 2003, Nature Medicine.

[111]  Mark S. Cohen,et al.  Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.

[112]  A. Haase,et al.  Quantification of regional blood volumes by rapid T1 mapping , 1993, Magnetic resonance in medicine.

[113]  R Weissleder,et al.  A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.

[114]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[115]  Alexander Petrovsky,et al.  Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. , 2002, Bioconjugate chemistry.

[116]  J. R. Griffiths,et al.  Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension. , 1990, British Journal of Cancer.

[117]  R G Steen,et al.  Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy. , 1988, Cancer research.

[118]  A Mogro-Campero,et al.  A high-temperature superconducting receiver for nuclear magnetic resonance microscopy. , 1993, Science.

[119]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[120]  J. Koutcher,et al.  Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination. , 1992, Cancer research.

[121]  R Weissleder,et al.  Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[122]  B. Rosen,et al.  MR Contrast Due to Microscopically Heterogeneous Magnetic Susceptibility: Numerical Simulations and Applications to Cerebral Physiology , 1991, Magnetic resonance in medicine.

[123]  T. Mareci,et al.  In vivo 1H magnetic resonance imaging and spectroscopy of the rat spinal cord using an inductively‐coupled chronically implanted RF coil , 2001, Magnetic resonance in medicine.

[124]  K. Minard,et al.  Picoliter 1H NMR Spectroscopy , 2002 .

[125]  R. Zhou,et al.  In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[126]  Rugar,et al.  Signal-to-noise ratios in inductive and mechanical detection of magnetic resonance. , 1993, Physical review letters.

[127]  Corrected equations for susceptibility-induced T2-shortening. , 1999, Journal of magnetic resonance.

[128]  R S Balaban,et al.  A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). , 2000, Journal of magnetic resonance.

[129]  C. Starmer,et al.  Indicator Transit Time Considered as a Gamma Variate , 1964, Circulation research.

[130]  Ming Zhao,et al.  Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.

[131]  Z. Bhujwalla,et al.  Glucose metabolism in RIF‐1 tumors after reduction in blood flow: An in Vivo 13C and 31P NMR study , 1994, Magnetic resonance in medicine.

[132]  D. Sodickson,et al.  A generalized approach to parallel magnetic resonance imaging. , 2001, Medical physics.

[133]  M. Garwood,et al.  Localized detection of glioma glycolysis using edited 1H MRS , 1993, Magnetic resonance in medicine.

[134]  T. Powles,et al.  Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment , 1998, NMR in biomedicine.

[135]  C. Ng,et al.  Gel‐entrapment of perfluorocarbons: A fluorine‐19 NMR spectroscopic method for monitoring oxygen concentration in cell perfusion systems , 1993, Magnetic resonance in medicine.

[136]  Richard L. Magin,et al.  High-Resolution Microcoil 1H-NMR for Mass-Limited, Nanoliter-Volume Samples , 1995, Science.

[137]  W. Danforth,et al.  Effect of pH on the kinetics of frog muscle phosphofructokinase. , 1966, The Journal of biological chemistry.

[138]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[139]  S. Rockwell,et al.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.

[140]  Nicolaas Bloembergen,et al.  Proton Relaxation Times in Paramagnetic Solutions , 1957 .

[141]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.

[142]  K. Zierler Theoretical Basis of Indicator‐Dilution Methods For Measuring Flow and Volume , 1962 .

[143]  Sheng-Kwei Song,et al.  Improved molecular imaging contrast agent for detection of human thrombus , 2003, Magnetic resonance in medicine.

[144]  D Matthaei,et al.  1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.

[145]  B R Rosen,et al.  Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.

[146]  H. Degani,et al.  Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[147]  D Artemov,et al.  In Vivo Selective Measurement of {1−13C}‐Glucose Metabolism in Tumors by Heteronuclear Cross Polarization , 1995, Magnetic resonance in medicine.

[148]  P. Okunieff,et al.  Tumor size dependent changes in a murine fibrosarcoma: use of in vivo 31P NMR for non-invasive evaluation of tumor metabolic status. , 1986, International journal of radiation oncology, biology, physics.

[149]  H. Merkle,et al.  Relationships Among Lactate Concentration, Blood Flow and Histopathologic Profiles in Rat C6 Glioma , 1996, NMR in biomedicine.

[150]  M. Garwood,et al.  Spectral editing with adiabatic pulses. , 1995, Journal of magnetic resonance. Series B.

[151]  Alan P Koretsky,et al.  Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. , 2003, Blood.

[152]  Peter C M van Zijl,et al.  Sensitive CEST agents based on nucleic acid imino proton exchange: Detection of poly(rU) and of a dendrimer‐poly(rU) model for nucleic acid delivery and pharmacology , 2003, Magnetic resonance in medicine.

[153]  Arvind P Pathak,et al.  Novel system for determining contrast agent concentration in mouse blood in vivo , 2004, Magnetic resonance in medicine.

[154]  I Barba,et al.  The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. , 1999, Cancer research.

[155]  A. Volk,et al.  Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultured as spheroids and as implanted tumors , 1994, NMR in biomedicine.

[156]  S. Cerdán,et al.  Imidazol-1-ylalkanoic acids as extrinsic 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume. , 1994, Bioorganic & medicinal chemistry.

[157]  Natarajan Raghunand,et al.  In vivo imaging of extracellular pH using 1H MRSI , 1999, Magnetic resonance in medicine.

[158]  R G Shulman,et al.  31P nuclear magnetic resonance evidence for the regulation of intracellular pH by Ehrlich ascites tumor cells , 1982, The Journal of cell biology.

[159]  I. Silver,et al.  ATP and Brain Function , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[160]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[161]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[162]  S. Williams,et al.  Immortalization and transformation are associated with specific alterations in choline metabolism. , 1996, Cancer research.

[163]  Z. H. Cho,et al.  Recent progress in NMR microscopy towards cellular imaging , 1990, Philosophical Transactions of the Royal Society of London. Series A: Physical and Engineering Sciences.

[164]  L. Ciobanu,et al.  Design and testing of high sensitivity microreceiver coil apparatus for nuclear magnetic resonance and imaging , 2001 .

[165]  Phosphatidylethanolamine synthesis in the normal and lymphomatous mouse liver; a 13C NMR study. , 1996, Anticancer research.

[166]  Arnd Schaff,et al.  Mechanically Detected Nuclear Magnetic Resonance at Room Temperature and Normal Pressure , 1997 .

[167]  M. Ogan,et al.  Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. , 1987, Investigative radiology.

[168]  P.-A. Besse,et al.  High-Q factor RF planar microcoils for micro-scale NMR spectroscopy , 2002 .

[169]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[170]  J R Griffiths,et al.  31P-NMR investigation of solid tumours in the living rat , 1981, Bioscience reports.

[171]  R. Kallman The phenomenon of reoxygenation and its implications for fractionated radiotherapy. , 1972, Radiology.

[172]  F Podo,et al.  In vivo 31P MRS of experimental tumours , 1993, NMR in biomedicine.

[173]  R S Balaban,et al.  Detection of proton chemical exchange between metabolites and water in biological tissues. , 1998, Journal of magnetic resonance.

[174]  C. Cheong,et al.  One micrometer resolution NMR microscopy. , 2001, Journal of magnetic resonance.

[175]  Dmitri Artemov,et al.  Magnetic resonance molecular imaging of the HER-2/neu receptor. , 2003, Cancer research.

[176]  M O Leach,et al.  Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells , 2002, British Journal of Cancer.

[177]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[178]  E. Haacke,et al.  Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.

[179]  B. Rosen,et al.  Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time? , 1993, Magnetic resonance in medicine.

[180]  Dmitri Artemov,et al.  MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.

[181]  Z. Bhujwalla,et al.  Energy metabolism, pH changes, and lactate production in RIF-1 tumors following intratumoral injection of glucose. , 1992, International journal of radiation oncology, biology, physics.

[182]  J. Bulte,et al.  Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. , 2001, Journal of the American Chemical Society.

[183]  Stasia A. Anderson,et al.  Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .

[184]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[185]  W. Thilly,et al.  Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study. , 1995, Cancer research.

[186]  A. Fischman,et al.  Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. , 1991, Radiology.

[187]  N. van Bruggen,et al.  Assessing tumor angiogenesis using macromolecular MR imaging contrast media , 1997, Journal of magnetic resonance imaging : JMRI.